Evoke Pharma, Inc. (EVOK)
NASDAQ: EVOK · Real-Time Price · USD
2.560
-0.080 (-3.03%)
At close: Jun 27, 2025, 4:00 PM
2.620
+0.060 (2.34%)
After-hours: Jun 27, 2025, 4:00 PM EDT
Evoke Pharma Market Cap
Evoke Pharma has a market cap or net worth of $5.17 million as of June 27, 2025. Its market cap has increased by 5.61% in one year.
Market Cap
5.17M
Enterprise Value
-2.30M
1-Year Change
5.61%
Ranking
Category
Stock Price
$2.56
Market Cap Chart
Since September 25, 2013, Evoke Pharma's market cap has decreased from $67.90M to $5.17M, a decrease of -92.38%. That is a compound annual growth rate of -19.66%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 27, 2025 | 3.90M | -40.91% |
| Dec 31, 2024 | 6.60M | 88.57% |
| Dec 29, 2023 | 3.50M | -61.11% |
| Dec 30, 2022 | 9.00M | -50.00% |
| Dec 31, 2021 | 18.00M | -73.57% |
| Dec 31, 2020 | 68.10M | 73.28% |
| Dec 31, 2019 | 39.30M | -9.03% |
| Dec 31, 2018 | 43.20M | 24.14% |
| Dec 29, 2017 | 34.80M | 39.76% |
| Dec 30, 2016 | 24.90M | 5.51% |
| Dec 31, 2015 | 23.60M | -34.63% |
| Dec 31, 2014 | 36.10M | -20.48% |
| Dec 31, 2013 | 45.40M | -33.14% |
View and export this data all the way back to 2013.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 696.15B |
| Johnson & Johnson | 366.71B |
| AbbVie | 322.03B |
| Novo Nordisk | 304.96B |
| UnitedHealth Group | 280.41B |
| Novartis AG | 235.85B |
| Abbott Laboratories | 233.80B |
| AstraZeneca | 217.42B |